Brickell Biotech Probability of Future Stock Price Finishing Over 2.24

BBIDelisted Stock  USD 1.79  0.34  23.45%   
Brickell Biotech's future price is the expected price of Brickell Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Brickell Biotech performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
  
Please specify Brickell Biotech's target price for which you would like Brickell Biotech odds to be computed.

Brickell Biotech Target Price Odds to finish over 2.24

The tendency of Brickell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 2.24  or more in 90 days
 1.79 90 days 2.24 
near 1
Based on a normal probability distribution, the odds of Brickell Biotech to move over $ 2.24  or more in 90 days from now is near 1 (This Brickell Biotech probability density function shows the probability of Brickell Stock to fall within a particular range of prices over 90 days) . Probability of Brickell Biotech price to stay between its current price of $ 1.79  and $ 2.24  at the end of the 90-day period is about 21.74 .
Considering the 90-day investment horizon Brickell Biotech has a beta of 0.6 suggesting as returns on the market go up, Brickell Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Brickell Biotech will be expected to be much smaller as well. Additionally Brickell Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Brickell Biotech Price Density   
       Price  

Predictive Modules for Brickell Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Brickell Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1.791.791.79
Details
Intrinsic
Valuation
LowRealHigh
1.461.461.97
Details
Naive
Forecast
LowNextHigh
1.911.911.91
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.431.631.84
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brickell Biotech. Your research has to be compared to or analyzed against Brickell Biotech's peers to derive any actionable benefits. When done correctly, Brickell Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Brickell Biotech.

Brickell Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Brickell Biotech is not an exception. The market had few large corrections towards the Brickell Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Brickell Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Brickell Biotech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.05
β
Beta against Dow Jones0.60
σ
Overall volatility
0.22
Ir
Information ratio -0.02

Brickell Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Brickell Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Brickell Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Brickell Biotech is not yet fully synchronised with the market data
Brickell Biotech may become a speculative penny stock
Brickell Biotech has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 404 K. Reported Net Loss for the year was (39.47 M) with loss before taxes, overhead, and interest of (27.83 M).
Brickell Biotech has about 17.29 M in cash with (36.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Brickell Biotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Brickell Stock often depends not only on the future outlook of the current and potential Brickell Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brickell Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.8 M
Cash And Short Term Investments26.9 M

Brickell Biotech Technical Analysis

Brickell Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Brickell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Brickell Biotech. In general, you should focus on analyzing Brickell Stock price patterns and their correlations with different microeconomic environments and drivers.

Brickell Biotech Predictive Forecast Models

Brickell Biotech's time-series forecasting models is one of many Brickell Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Brickell Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Brickell Biotech

Checking the ongoing alerts about Brickell Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Brickell Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Brickell Biotech is not yet fully synchronised with the market data
Brickell Biotech may become a speculative penny stock
Brickell Biotech has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 404 K. Reported Net Loss for the year was (39.47 M) with loss before taxes, overhead, and interest of (27.83 M).
Brickell Biotech has about 17.29 M in cash with (36.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Brickell Stock

If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bonds Directory
Find actively traded corporate debentures issued by US companies